News related to Imodium (Loperamide) and/or conditions it is approved for
Avoid Hospital Visits If You Have Had Diarrhea And Vomiting Symptoms During Last 48 Hours, Say Bristol Hospitals, England
Source: GastroIntestinal / Gastroenterology News From Medical News Today [2008.11.19]
Hospitals across Bristol are reminding people to avoid visiting if they have had symptoms of diarrhoea and vomiting in the previous 48 hours. Over the past few weeks, cases of Norovirus - the winter vomiting virus - have increased in the community. Norovirus is brought into hospitals from the local community and is easily spread by contact with people suffering diarrhoea and vomiting who may have contaminated the environment.
Antibiotics May Not Cause Diarrheal Bacteria
Source: MedicineNet Clostridium Difficile Colitis Specialty [2008.10.13]
Title: Antibiotics May Not Cause Diarrheal Bacteria
Category: Health News
Created: 10/11/2008 2:00:00 AM
Last Editorial Review: 10/13/2008
Vaccine Skin Patch Prevents Travelers' Diarrhea
Source: MedicineNet Travel Medicine Specialty [2008.06.12]
Title: Vaccine Skin Patch Prevents Travelers' Diarrhea
Category: Health News
Created: 6/12/2008 2:00:00 AM
Last Editorial Review: 6/12/2008
Travelers' Diarrhea
Source: MedicineNet Cholera Specialty [2007.11.16]
Title: Travelers' Diarrhea
Category: Diseases and Conditions
Created: 4/3/1999 12:40:00 PM
Last Editorial Review: 11/16/2007
Diarrhea: Moms Uninformed About Rotavirus Illness
Source: MedicineNet Rotavirus Specialty [2007.05.09]
Title: Diarrhea: Moms Uninformed About Rotavirus Illness
Category: Doctor's Views
Created: 11/28/2005
Last Editorial Review: 5/9/2007
Diarrhea
Source: MedicineNet Lymphocytic Colitis Specialty [2004.05.14]
Title: Diarrhea
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 5/14/2004
A Faster Test For The Food Protein That Triggers Celiac Disease - Analytical Chemistry Journal
Source: GastroIntestinal / Gastroenterology News From Medical News Today [2008.11.14]
Researchers in Spain and the United Kingdom are reporting development of a faster test for identifying the food protein that triggers celiac disease, a difficult-to-diagnose digestive disease involving the inability to digest protein called gluten that occurs in wheat, oats, rye, and barley. The finding could help millions of people avoid diarrhea, bloating, and other symptoms that occur when they unknowingly eat foods containing gluten.
C Difficile Catching Up With MRSA
Source: MRSA / Drug Resistance News From Medical News Today [2008.11.12]
Clostridium difficile, a life-threatening bacterium that causes diarrhea and more serious intestinal problems, is closing in on MRSA as the most prevalent and troublesome hospital-acquired superbug in the US; it is rapidly developing an antibiotic resistant form and a new survey suggests it is infecting between 6 and 20 times more patients than previously thought.
While Infecting Humans Tiny Fungi May Reproduce Sexually
Source: Gout News From Medical News Today [2008.10.31]
A fungus called microsporidia that causes chronic diarrhea in AIDS patients, organ transplant recipients and travelers has been identified as a member of the family of fungi that have been discovered to reproduce sexually. A team at Duke University Medical Center has proven that microsporidia are true fungi and that this species most likely undergoes a form of sexual reproduction during infection of humans and other host animals.
The Effectiveness Of Probiotics In IBS
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.10.07]
Several studies presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando highlight the safety and efficacy of probiotics in improving symptoms and normalizing bowel movement frequency in patients suffering from constipation or diarrhea related to Irritable Bowel Syndrome (IBS).
Salix Presents New Phase II Data Evidence Demonstrating The Clinical Utility Of Rifaximin In Irritable Bowel Syndrome (IBS)
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.10.06]
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced findings from two analyses of a Phase II clinical trial that demonstrate the utility of rifaximin, a non-absorbed, gut-selective antibiotic, in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS).
|
